Heron Therapeutics, Inc. (HRTX) — Stock Score Summary

Heron Therapeutics, Inc. (HRTX) has a MoatMap StockRank of 12/100 based on Quality (35/100), Value (42/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. Heron Therapeutics lacks the pricing power, high ROIC, and clear macro tailwinds required to justify inclusion in our concentrated portfolio.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing novel therapies for unmet medical needs in oncology and pain management. The company possesses a portfolio of commercialized products and a pipeline addressing significant market opportunities in supportive care and post-operative pain. Heron is known for its innovative drug delivery technologies, including long-acting formulations, designed to improve patient convenience and outcomes.

Key Financial Metrics

Price$0.40
Market Cap$169M
Price/Book11.24
Return on Invested Capital-6.6%
Debt/Equity1550.12
Gross Margin62.8%
Operating Margin-13.7%
Revenue Growth-10.8%
Free Cash Flow$-18M

Heron Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Heron Therapeutics, Inc.’s (HRTX) StockRank?
MoatMap’s StockRank for Heron Therapeutics, Inc. (HRTX) is 12/100, with a Strong Sell signal. It is a composite of Quality (35), Value (42), and Momentum (19) factor ranks across MoatMap’s 19,000+ stock universe.
Does Heron Therapeutics, Inc. have an economic moat?
Heron Therapeutics, Inc. (HRTX) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Heron Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Heron Therapeutics, Inc. (HRTX) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Heron Therapeutics, Inc. in?
Heron Therapeutics, Inc. (HRTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksHRTX deep dive reportAI ChampionsHow we score stocksSense-check another stock